Today’s guest is Dr. Kathryn Torok, a pediatric rheumatologist at the University of Pittsburgh and UPMC Children’s Hospital of Pittsburgh, where she directs the Pediatric Craniofacial Scleroderma Clinic. Scleroderma in children is rare, about five in 100,000 develop localized disease, and only about one in a million develop systemic disease. It's crucial to treat to target as early as possible. I learned so much from Dr. Torok about how scleroderma affects children and the best approaches to ...
All content for Mogil's Mobcast-A Scleroderma Chat is the property of Ann and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Today’s guest is Dr. Kathryn Torok, a pediatric rheumatologist at the University of Pittsburgh and UPMC Children’s Hospital of Pittsburgh, where she directs the Pediatric Craniofacial Scleroderma Clinic. Scleroderma in children is rare, about five in 100,000 develop localized disease, and only about one in a million develop systemic disease. It's crucial to treat to target as early as possible. I learned so much from Dr. Torok about how scleroderma affects children and the best approaches to ...
Episode #102 Dr. Shannon Herndon MD: Rheumatology Fellow
Mogil's Mobcast-A Scleroderma Chat
40 minutes
7 months ago
Episode #102 Dr. Shannon Herndon MD: Rheumatology Fellow
When you hear the term palliative care, what comes to mind? I’ll admit I used to think it meant something very different. But today’s guest, Dr. Shannon Herndon, helped reshape my understanding. Dr. Herndon joins us to talk about how palliative care can support scleroderma warriors not just at the end of life, but throughout the journey of living with this disease.You may remember a recent survey circulating in our community Dr. Herndon was behind it. The goal? To better understand how pallia...
Mogil's Mobcast-A Scleroderma Chat
Today’s guest is Dr. Kathryn Torok, a pediatric rheumatologist at the University of Pittsburgh and UPMC Children’s Hospital of Pittsburgh, where she directs the Pediatric Craniofacial Scleroderma Clinic. Scleroderma in children is rare, about five in 100,000 develop localized disease, and only about one in a million develop systemic disease. It's crucial to treat to target as early as possible. I learned so much from Dr. Torok about how scleroderma affects children and the best approaches to ...
